0088M0.KQ Mezoo Co., Ltd.
- Market cap
- KRW 152B
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0088M0.KQ undervalued?
Graham numberThe Graham number of Mezoo Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mezoo Co., Ltd. fundamental analysis
No fundamental analysis for Mezoo Co., Ltd. yet.
Mezoo Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mezoo Co., Ltd.
Mezoo Co., Ltd. develops, manufactures, and sells wearable smart patches, mobile, and web-based software in South Korea. It offers HiCardi system, a cardiac monitoring technology that sends various patient data to a secured cloud that enables analyzing and monitoring 17 different cardiac arrhythmias and real-time monitoring for cardiac, respiratory, temperature, and activity; vetwave, a mobile cardiac telemetry for animal; and µBIC, a bio-processor. It also provides ambulato…
Full company profileFinancial statements of Mezoo Co., Ltd. are not available yet.
Mezoo Co., Ltd. dividends
Mezoo Co., Ltd. has not paid dividends in the last 1 fiscal years.
Who owns Mezoo Co., Ltd.
- Insiders 72.55%
- Institutions 7.42%
- Public & others 20.04%
- Shares outstanding 9.72M
Mezoo Co., Ltd. company profile
- Company name
- Mezoo Co., Ltd.
- Ticker
- 0088M0.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Address
- WMIT Building, Wonju-si, South Korea, 26354
- Phone
- 82 3 3761 2006
- Website
- me-zoo.com
About Mezoo Co., Ltd.
Mezoo Co., Ltd. develops, manufactures, and sells wearable smart patches, mobile, and web-based software in South Korea. It offers HiCardi system, a cardiac monitoring technology that sends various patient data to a secured cloud that enables analyzing and monitoring 17 different cardiac arrhythmias and real-time monitoring for cardiac, respiratory, temperature, and activity; vetwave, a mobile cardiac telemetry for animal; and µBIC, a bio-processor. It also provides ambulatory Remote Patient Monitoring (aRPM) solutions that connect care inside and outside the hospital, powered by biomedical telemetry technology. It caters to the healthcare sector, specifically cardiac monitoring and remote patient diagnostics. The company was founded in 2007 and is based in Wonju-si, South Korea.
Mezoo Co., Ltd. management
6- Mr. Junghwan Park Ph.D.Founder, CEO, President & Representative Director · born 1974
- Mr. Yeongil Joo CPACFO & Executive Director · born 1972
- Ms. Mihye Song Ph.D.Chief Technology Officer · born 1979
- Mr. Yeonghoon Kim M.D., Ph.D.Chief Medical Officer · born 1958
- Mr. Sungpil Cho Ph.D.VP, Chief Creative Officer, Head of Clinical Research & Director · born 1978
- Mr. Hoon Sim Ph.D.Head of CX Division & Executive Officer · born 1982